Login / Signup

Innate immune responsive inflammation in development of progressive myopia.

Suqi PanJianshu YuanYuanhui JinXiaotian LiuShanjun WuYuwen WangHongyan YaoLingyun Cheng
Published in: Eye (London, England) (2024)
sICAM-1 and MCP-1 in ocular fluid may be indicative biomarkers for progressive high myopia and the underneath autoimmune inflammation. sICAM-1 may be used as a monitoring biomarker for development of pathologic myopia.
Keyphrases
  • multiple sclerosis
  • innate immune
  • oxidative stress
  • optic nerve
  • neoadjuvant chemotherapy
  • cancer therapy
  • radiation therapy
  • drug delivery
  • lymph node
  • optical coherence tomography